IV mutation literature information.


  Structure-Based Modification of an Anti-neuraminidase Human Antibody Restores Protection Efficacy against the Drifted Influenza Virus.
 PMID: 33024040       2020       mBio
Result: Prophylactic and therapeutic studies were performed to explore the protection efficacy of both Z2B3 and Z2B3-D102R against challenge with different viruses in vivo.
Result: The NA inhibition ability of Z2B3 and Z2B
Result: The MUNANA-based NA inhibition assay showed that both Z2B3 and Z2B3-D102R inhibit NA activity of the 18N1 protein, with 50% inhibitory concentrations (IC50s) of 118 and 386 nM, respectively.



Browser Board

 Co-occurred Entities




   Filtrator